1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019

Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput mass spectroscopy, glycan microarrays, and carbohydrate chemistry are helping to unravel the complexity resulting from this diversity.

This report segment the global glycomics market by application, end users, products, and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies. The product segments included in this report are enzymes; instruments; kits; and reagents. Glycosidases; glycosyltransferases; neuraminidases; sialyltransferases; and other enzymes are subsegments of the enzymes product segment. Antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometers; and other glycomics instruments are subsegments of the instruments product segment. Glycan labeling kits; glycan purification kits; glycan release kits; and other glycomics kits are subsegments of the kits market. Glycoproteins; monosaccharaides; oligosaccharides; and other glycomics reagents are subsegments of the reagents product segment.

The geographic segments included in this report are Asia, Europe, North America and Rest of the World (RoW). Asia is further divided into the regional segments of China, India, Japan, and Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada, and the U.S. RoW encompasses the Middle East and Africa, Pacific and Oceania, and South America.

The key drivers for this market are the rising R&D expenditure by pharmaceutical and biotech companies, and increasing public and private funding for proteomics and glycomics research. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the glycomics enzymes, instruments, kits, and reagents market.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global glycomics enzymes, instruments, kits, and reagents market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their glycomics enzymes, instruments, kits and reagents market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the glycomics enzymes, instruments, kits and reagents market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of top players in the glycomics enzymes, instruments, kits and reagents market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the glycomics market
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the glycomics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various glycomics enzymes, instruments, kits and reagents products across geographies
• Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the glycomics enzymes, instruments, kits and reagents market

Table Of Contents

Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) and by End User - Global Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKETS COVERED 16
1.3 MARKET SCOPE 18
1.4 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 DESCRIPTION OF THE GLYCOMICS DEMAND MODEL 21
2.1.1 GROWTH IN RandD EXPENDITURE 22
2.1.2 INCREASING NUMBER OF BIOTECHNOLOGY PATENTS 22
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET CRACKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 25
2.4.1 KEY DATA FROM SECONDARY SOURCES 26
2.4.2 KEY DATA FROM PRIMARY SOURCES 26
2.4.2.1 Key Industry Insights 27
2.4.3 ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL GLYCOMICS MARKET 32
4.2 LIFE CYCLE ANALYSIS, BY GEOGRAPHY 33
5 MARKET OVERVIEW 35
5.2 INTRODUCTION 36
5.3 MARKET SEGMENTATION 36
5.3.1 GLYCOMICS MARKET, BY PRODUCT 36
5.3.2 GLYCOMICS MARKET, BY APPLICATION 36
5.3.3 GLYCOMICS MARKET, BY END USER 37
5.4 MARKET DYNAMICS 37
5.4.1 DRIVERS 38
5.4.1.1 Increasing government and private funding for proteomics and glycomics research 38
5.4.1.2 Increasing pharmaceutical and biotechnology RandD expenditure 39
5.4.1.3 Growing proteomics market 39
5.4.1.4 Technological advancements for glycomics research 39


5.4.2 RESTRAINTS 40
5.4.2.1 High degree of consolidation acts as an entry barrier for new entrants 40
5.4.3 OPPORTUNITIES 40
5.4.3.1 Increased use of personalized medicine 40
5.4.3.2 Developing countries present significant opportunities for the glycomics market 40
5.4.4 CHALLENGES 41
5.4.4.1 Stringent regulatory frameworks and time-consuming approval processes act as major challenges 41
6 INDUSTRY INSIGHTS 42
6.1 INTRODUCTION 42
6.2 VALUE CHAIN ANALYSIS 42
6.3 SUPPLY CHAIN ANALYSIS 43
6.3.1 KEY INFLUENCERS 44
6.4 PORTER'S FIVE FORCES ANALYSIS 45
6.4.1 THREAT FROM NEW ENTRANTS 45
6.4.2 THREAT FROM SUBSTITUTES 45
6.4.3 BARGAINING POWER OF BUYERS 46
6.4.4 BARGAINING POWER OF SUPPLIERS 46
6.4.5 INTENSITY OF RIVALRY 46
6.5 STRATEGIC BENCHMARKING 46
6.5.1 NEW PRODUCT LAUNCHES 46
7 GLYCOMICS MARKET, BY PRODUCT 48
7.1 INTRODUCTION 49
7.2 ENZYMES 51
7.2.1 GLYCOSIDASES 53
7.2.2 GLYCOSYLTRANSFERASES 54
7.2.3 NEURAMINIDASES 55
7.2.4 SIALYLTRANSFERASES 56
7.2.5 OTHER GLYCOMICS ENZYMES 57
7.3 INSTRUMENTS 58
7.3.1 ANTIBODY ARRAYS 60
7.3.2 HPLC 61
7.3.3 LECTIN ARRAYS 63
7.3.4 MALDI-TOF 64
7.3.5 MASS SPECTROMETERS 65
7.3.6 OTHER GLYCOMICS INSTRUMENTS 66
7.4 KITS 68
7.4.1 GLYCAN LABELING KITS 69
7.4.2 GLYCAN PURIFICATION KITS 71
7.4.3 GLYCAN RELEASE KITS 72
7.4.4 OTHER GLYCOMICS KITS 73
7.5 REAGENTS 74
7.5.1 GLYCOPROTEINS 75
7.5.2 MONOSACCHARIDES 76
7.5.3 OLIGOSACCHARIDES 77
7.5.4 OTHER REAGENTS 79
8 GLYCOMICS MARKET, BY APPLICATION 81
8.1 INTRODUCTION 82
8.2 DIAGNOSTICS 84
8.3 DRUG DISCOVERY and DEVELOPMENT 85
8.4 IMMUNOLOGY 87
8.5 ONCOLOGY 89
8.6 OTHER APPLICATIONS 91
9 GLYCOMICS MARKET, BY END USER 93
9.1 INTRODUCTION 94
9.2 ACADEMIC RESEARCH INSTITUTES 96
9.3 CONTRACT RESEARCH ORGANIZATIONS 98
9.4 PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES 99
10 GEOGRAPHIC ANALYSIS 101
10.1 INTRODUCTION 102
10.2 ASIA 103
10.2.1 CHINA 109
10.2.2 INDIA 110
10.2.3 JAPAN 111
10.2.4 REST OF ASIA 112
10.3 EUROPE 113
10.3.1 FRANCE 119
10.3.2 GERMANY 120
10.3.3 ITALY 121
10.3.4 SPAIN 122
10.3.5 U.K. 123
10.3.6 ROE 124
10.4 NORTH AMERICA 126
10.4.1 CANADA 131
10.4.2 U.S. 132
10.5 REST OF THE WORLD (ROW) 134
10.5.1 MIDDLE EAST AND AFRICA 139
10.5.2 PACIFIC AND OCEANIA 139
10.5.3 SOUTH AMERICA 140
11 COMPETITIVE LANDSCAPE 142
11.1 OVERVIEW 142
11.2 MARKET SHARE ANALYSIS, GLYCOMICS ENZYMES, KITS, AND REGENTS MARKET 143
11.3 MARKET SHARE ANALYSIS, GLYCOMCIS INSTRUMENTS MARKET 144
11.4 COMPETITIVE SITUATION AND TRENDS 146
11.4.1 NEW PRODUCT LAUNCHES 146
11.4.2 EXPANSIONS 147
11.4.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 148
11.4.4 MERGERS AND ACQUISITIONS 150
11.4.5 OTHER DEVELOPMENTS 151
12 COMPANY PROFILES 152
12.1 INTRODUCTION 152
12.2 BRUKER CORPORATION 153
12.3 NEW ENGLAND BIOLABS 158
12.4 SHIMADZU CORPORATION 160
12.5 SIGMA-ALDRICH CORPORATION 166
12.6 TAKARA BIO 169
12.7 WATERS CORPORATION 172
12.8 AGILENT TECHNOLOGIES, INC. 176
12.9 DANAHER CORPORATION 180
12.10 PROZYME 183
12.11 THERMO FISHER SCIENTIFIC INC. 186
*Details on Financials, Product and Services, Strategy, and Developments Might Not Be Captured in
Case of Unlisted Companies.
13 APPENDIX 191
13.1 INSIGHTS OF INDUSTRY EXPERTS 191
13.2 DISCUSSION GUIDE 191
13.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 195
13.4 AVAILABLE CUSTOMIZATIONS 197
13.5 RELATED REPORTS 197


LIST OF TABLES

TABLE 1 GLYCOMICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 50
TABLE 2 GLYCOMICS ENZYMES MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 52
TABLE 3 GLYCOMICS ENZYMES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 52
TABLE 4 GLYCOSIDASES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 53
TABLE 5 GLYCOSYLTRANSFERASES MARKET SIZE , BY GEOGRAPHY,
2012-2019 ($MILLION) 55
TABLE 6 NEURAMINIDASES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 56
TABLE 7 SIALYLTRANSFERASES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 57
TABLE 8 OTHER GLYCOMICS ENZYMES MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 58
TABLE 9 GLYCOMICS INSTRUMENTS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 60
TABLE 10 GLYCOMICS INSTRUMENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 60
TABLE 11 ANTIBODY ARRAYS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 61
TABLE 12 HPLC INSTRUMENTS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 62
TABLE 13 LECTIN ARRAYS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 63
TABLE 14 MALDI-TOF INSTRUMENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 65
TABLE 15 MASS SPECTROMETRY INSTRUMENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 66
TABLE 16 OTHER GLYCOMICS INSTRUMENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 67
TABLE 17 GLYCOMICS KITS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 69
TABLE 18 GLYCOMICS KITS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 69
TABLE 19 GLYCAN LABELING KITS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 70
TABLE 20 GLYCAN PURIFICATION KITS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 71
TABLE 21 GLYCAN RELEASE KITS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 72
TABLE 22 OTHER GLYCOMICS KITS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 73
TABLE 23 GLYCOMICS REAGENTS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 75
TABLE 24 GLYCOMICS REAGENTS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 75
TABLE 25 GLYCOPROTEINS REAGENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 76
TABLE 26 MONOSACCHARIDES REAGENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 77
TABLE 27 OLIGOSACCHARIDES REAGENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 78
TABLE 28 OTHER GLYCOMICS REAGENTS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 80
TABLE 29 GLYCOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 83
TABLE 30 GLYCOMICS MARKET SIZE FOR DIAGNOSTICS, BY REGION,
2012-2019 ($MILLION) 84
TABLE 31 GLYCOMICS MARKET SIZE FOR DRUG DISCOVERY AND DEVELOPMENT,
BY REGION, 2012-2019 ($MILLION) 86
TABLE 32 GLYCOMICS MARKET SIZE FOR IMMUNOLOGY, BY GEOGRAPHY,
2012-2019 ($MILLION) 88
TABLE 33 GLYCOMICS MARKET SIZE FOR ONCOLOGY, BY GEOGRAPHY,
2012-2019 ($MILLION) 90
TABLE 34 GLYCOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY GEOGRAPHY,
2012-2019 ($MILLION) 92
TABLE 35 GLYCOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 96
TABLE 36 GLYCOMICS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY GEOGRAPHY, 2012-2019 ($MILLION) 97
TABLE 37 GLYCOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS,
BY GEOGRAPHY, 2012-2019 ($MILLION) 99
TABLE 38 GLYCOMICS MARKET SIZE FOR PHARMACEUTICAL and BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2012-2019 ($MILLION) 100
TABLE 39 GLYCOMICS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 102
TABLE 40 ASIA: GLYCOMICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 104
TABLE 41 ASIA: GLYCOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 104
TABLE 42 ASIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 105
TABLE 43 ASIA: GLYCOMICS ENZYMES MARKET SIZE, BY PRODUCT TYPE,
2012-2019 ($MILLION) 106
TABLE 44 ASIA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012-2019 ($MILLION) 106
TABLE 45 ASIA: GLYCOMICS KITS MARKET SIZE, BY PRODUCT TYPE, 2012-2019 ($MILLION) 107
TABLE 46 ASIA: GLYCOMICS REAGENTS MARKET SIZE, BY PRODUCT TYPE,
2012-2019 ($MILLION) 107
TABLE 47 ASIA: GLYCOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 107
TABLE 48 EUROPE: GLYCOMICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 114
TABLE 49 EUROPE: GLYCOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 114
TABLE 50 EUROPE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 115
TABLE 51 EUROPE: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 116
TABLE 52 EUROPE: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 116
TABLE 53 EUROPE: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 117
TABLE 54 EUROPE: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 117
TABLE 55 EUROPE: GLYCOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 118
TABLE 56 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY GEOGRAPHY,
2012-2019 ($MILLION) 127
TABLE 57 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 127
TABLE 58 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 128
TABLE 59 NORTH AMERICA: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 128
TABLE 60 NORTH AMERICA: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 129
TABLE 61 NORTH AMERICA: GLYCOMICS KITS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 129
TABLE 62 NORTH AMERICA: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 130
TABLE 63 NORTH AMERICA: GLYCOMICS MARKET SIZE, BY APPLICATION,
2012-2019 ($MILLION) 130
TABLE 64 ROW: GLYCOMICS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 134
TABLE 65 ROW: GLYCOMICS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 135
TABLE 66 ROW: GLYCOMICS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 135
TABLE 67 ROW: GLYCOMICS ENZYMES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 136
TABLE 68 ROW: GLYCOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 136
TABLE 69 ROW: GLYCOMICS KITS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 137
TABLE 70 ROW: GLYCOMICS REAGENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 137
TABLE 71 ROW: GLYCOMICS MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 137
TABLE 72 NEW PRODUCT LAUNCHES, 2012-2014 147
TABLE 73 EXPANSIONS, 2012-2013 148
TABLE 74 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2011-2014 149
TABLE 75 MERGER AND ACQUISITIONS, 2011-2014 150
TABLE 76 OTHER DEVELOPMENTS, 2012-2013 151



LIST OF FIGURES

FIGURE 1 GLOBAL GLYCOMICS MARKET 16
FIGURE 2 RESEARCH METHODOLOGY 20
FIGURE 3 INCREASED RandD EXPENDITURE ON GLYCOMICS WILL DRIVE THE GLOBAL MARKET 22
FIGURE 4 INCREASING NUMBER OF BIOTECHNOLOGY PATENTS REFLECT THE INCREASED RESEARCH IN THE GLYCOMICS MARKET 23
FIGURE 5 BOTTOM-UP APPROACH 24
FIGURE 6 TOP-DOWN APPROACH 24
FIGURE 7 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, and REGION 25
FIGURE 8 ENZYMES ARE EXPECTED TO BE THE FASTEST-GROWING PRODUCT SEGMENT IN THE FORECAST PERIOD 28
FIGURE 9 GLYCOSIDASES HAS THE LARGEST SHARE OF THE GLYCOMICS ENZYMES MARKET 29
FIGURE 10 MASS SPECTROMETRY IS EXPECTED TO GROW AT THE HIGHEST RATE IN THE FORECAST PERIOD 29
FIGURE 11 GLYCAN RELEASE KITS TO DOMINATE THE GLYCOMICS KITS MARKET 30
FIGURE 12 OLIGOSACCHARIDES COMMAND THE LARGEST SHARE OF THE GLYCOMICS REAGENTS MARKET 30
FIGURE 13 INCREASING FUNDING IN GLYCOMICS AND PROTEOMICS RESEARCH WILL DRIVE THE NORTH AMERICAN GLYCOMICS MARKET 31
FIGURE 14 ATTRACTIVE OPPORTUNITIES IN GLYCOMICS MARKET 32
FIGURE 15 GLYCOMICS ENZYMES TO ACCOUNT FOR LARGEST MARKET SHARE (2014) 32
FIGURE 16 NORTH AMERICA TO BE THE FASTEST GROWING GLYCOMICS MARKET 33
FIGURE 17 ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES (2014) 33
FIGURE 18 GLYCOMICS MARKET SEGMENTATION, BY PRODUCT 36
FIGURE 19 GLYCOMICS MARKET SEGMENTATION, BY APPLICATION 37
FIGURE 20 GLYCOMICS MARKET SEGMENTATION, BY END USER 37
FIGURE 21 INCREASING GOVERNMENT AND PRIVATE FUNDING FOR PROTEOMICS AND GLYCOMICS RESEARCH WILL SPUR THE DEMAND FOR GLYCOMICS PRODUCTS 38
FIGURE 22 MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE 42
FIGURE 23 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES 44
FIGURE 24 HIGH CAPITAL INVESTMENT TO RESTRICT ENTRY OF NEW PLAYERS 45
FIGURE 25 MARKET LEADERS ADOPTED ORGANIC GROWTH STRATEGY OF NEW PRODUCT LAUNCHES 47
FIGURE 26 GLYCOMICS MARKET SEGMENTATION, BY PRODUCT 49
FIGURE 27 GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 (MARKET SIZE AND GROWTH RATES) 50
FIGURE 28 GLYCOMICS ENZYMES MARKET, BY PRODUCT 51
FIGURE 29 GLYCOSIDASES WILL BE THE FASTEST-GROWING SEGMENT IN GLYCOMICS ENZYMES MARKET IN THE FORECAST PERIOD 51
FIGURE 30 NORTH AMERICA TO COMMAND LARGEST SHARE OF GLYCOSIDASES ENZYMES MARKET IN 2014 53
FIGURE 31 NORTH AMERICA WILL BE THE FASTEST-GROWING SEGMENT IN THE GLYCOSYLTRANSFERASES MARKET IN THE FORECAST PERIOD 54
FIGURE 32 EUROPE WILL BE THE FASTEST-GROWING SEGMENT IN THE NEURAMINIDASES MARKET IN 2014 55
FIGURE 33 NORTH AMERICA TO COMMAND LARGEST SHARE IN THE SIALYLTRANSFERASES MARKET IN 2014 56
FIGURE 34 EUROPE WILL BE THE FASTEST-GROWING SEGMENT IN THE OTHER GLYCOMICS ENZYMES MARKET IN THE FORECAST PERIOD 58
FIGURE 35 GLYCOMICS INSTRUMENTS MARKET, BY PRODUCT 59
FIGURE 36 MASS SPECTROMETRY INSTRUMENTS WILL BE THE FASTEST-GROWING SEGMENT IN GLYCOMICS INSTRUMENTS MARKET IN THE FORECAST PERIOD 59
FIGURE 37 EUROPE TO BE THE FASTEST-GROWING MARKET FOR ANTIBODY ARRAYS IN THE FORECAST PERIOD 61
FIGURE 38 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR HPLC INSTRUMENTS IN THE FORECAST PERIOD 62
FIGURE 39 NORTH AMERICA TO COMMAND THE LARGEST SHARE BUT EUROPE TO BE THE FASTEST-GROWING MARKET FOR LECTIN ARRAYS 63
FIGURE 40 NORTH AMERICA COMMANDS THE LARGEST SHARE IN THE MALDI-TOF INSTRUMENTS MARKET IN 2014 64
FIGURE 41 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR MASS SPECTROMETRY INSTRUMENTS 66
FIGURE 42 ASIA TO COMMAND A LARGER SHARE THAN EUROPE IN THE OTHER GLYCOMICS INSTRUMENTS MARKET IN 2014 67
FIGURE 43 GLYCOMICS KITS MARKET, BY PRODUCT 68
FIGURE 44 GLYCAN RELEASE KITS WILL BE THE FASTEST-GROWING SEGMENT IN GLYCOMICS KITS MARKET IN THE FORECAST PERIOD 68
FIGURE 45 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR GLYCAN LABELING KITS 70
FIGURE 46 NORTH AMERICA TO COMMAND THE LARGEST SHARE IN THE GLYCAN PURIFICATION KITS MARKET IN 2014 71
FIGURE 47 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR GLYCAN RELEASE KITS 72
FIGURE 48 NORTH AMERICA TO COMMAND THE LARGEST SHARE, BUT EUROPE TO BE THE FASTEST-GROWING MARKET FOR OTHER GLYCOMICS KITS 73
FIGURE 49 GLYCOMICS REAGENTS MARKET, BY PRODUCT 74
FIGURE 50 OLIGOSACCHARIDES REAGENTS WILL BE THE FASTEST-GROWING SEGMENT IN THE GLYCOMICS REAGENTS MARKET IN THE FORECAST PERIOD 74
FIGURE 51 NORTH AMERICA TO COMMAND THE LARGEST SHARE IN THE GLYCOPROTEINS REAGENTS MARKET IN 2014 76
FIGURE 52 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR MONOSACCHARIDES 77
FIGURE 53 NORTH AMERICA IS THE LARGEST AND FASTEST-GROWING MARKET FOR OLIGOSACCHARIDES 78
FIGURE 54 EUROPE IS THE LARGEST AND FASTEST-GROWING MARKET FOR OTHER GLYCOMICS REAGENTS 79
FIGURE 55 GLYCOMICS MARKET SEGMENTATION, BY APPLICATION 82
FIGURE 56 GLOBAL GLYCOMICS MARKET, BY APPLICATION, 2014
(MARKET SIZE and GROWTH RATE) 82
FIGURE 57 DRUG DISCOVERY and DEVELOPMENT WILL BE THE FASTEST-GROWING APPLICATION SEGMENT OF THE GLYCOMICS MARKET 83
FIGURE 58 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE DIAGNOSTICS SEGMENT 84
FIGURE 59 NORTH AMERICA COMMANDS THE LARGEST SHARE IN THE DRUG DISCOVERY and DEVELOPMENT APPLICATION SEGMENT 86
FIGURE 60 INCREASE RESEARCH APPLICATION OF EPIGENETICS IN IMMUNOLOGY TO AID THE GROWTH OF THIS APPLICATION SEGMENT 87
FIGURE 61 NORTH AMERICA COMMANDS THE LARGEST SHARE IN IMMUNOLOGY OWING TO INCREASED RESEARCH ACTIVITIES 88
FIGURE 62 NORTH AMERICA TO COMMAND THE LARGEST SHARE IN ONCOLOGY DUE TO HIGH DEGREE OF FUNDING IN CANCER RESEARCH IN THIS REGION 90
FIGURE 63 EUROPE COMMANDS THE LARGEST SHARE IN THE OTHER APPLICATIONS SEGMENT 91
FIGURE 64 GLYCOMICS MARKET SEGMENTATION, BY END USER 94
FIGURE 65 GLYCOMICS MARKET SIZE, BY END USER, 2014 (MARKET SIZE and GROWTH RATES) 95
FIGURE 66 ACADEMIC RESEARCH INSTITUTES WILL BE THE FASTEST-GROWING END-USER SEGMENT 95
FIGURE 67 NORTH AMERICA WILL BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT DUE TO INCREASED FUNDING FOR GLYCOMICS RESEARCH 97
FIGURE 68 EUROPE WILL BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT DUE TO INCREASING PARTNERSHIPS BETWEEN RESEARCH INSTITUTES AND BIOTECHNOLOGY COMPANIES 98
FIGURE 69 EUROPE WILL BE THE FASTEST-GROWING SEGMENT DUE TO INCREASED OUTSOURCING OF DRUG DISCOVERY RESEARCH ACTIVITIES TO THIS REGION 100
FIGURE 70 NORTH AMERICA HOLDS LARGEST SHARE OF GLOBAL GLYCOMICS MARKET 102
FIGURE 71 CHINA COMMANDS 35% OF ASIAN GLYCOMICS MARKET 103
FIGURE 72 ASIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 105
FIGURE 73 ASIA: GLYCOMICS MARKET, BY PRODUCT (2014 VS. 2019) 108
FIGURE 74 CHINA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 109
FIGURE 75 INDIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 110
FIGURE 76 JAPAN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 111
FIGURE 77 ROA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 112
FIGURE 78 GERMANY DOMINATES EUROPEAN GLYCOMICS MARKET 113
FIGURE 79 EUROPE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 115
FIGURE 80 EUROPE: GLYCOMICS MARKET, BY PRODUCT (2014 VS. 2019) 119
FIGURE 81 FRANCE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019, ($MILLION) 120
FIGURE 82 GERMANY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 121
FIGURE 83 ITALY: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019, ($MILLION) 122
FIGURE 84 SPAIN: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 123
FIGURE 85 U.K.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 124
FIGURE 86 ROE: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 125
FIGURE 87 NORTH AMERICA COMMANDS THE LARGEST SHARE OF GLYCOMICS MARKET 126
FIGURE 88 NORTH AMERICA: GLYCOMICS MARKET, BY PRODUCT (2014 VS. 2019) 127
FIGURE 89 NORTH AMERICA: GLYCOMICS MARKET, BY PRODUCT (2014 VS. 2019) 131
FIGURE 90 CANADA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 132
FIGURE 91 U.S.: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 133
FIGURE 92 ROW: SOUTH AMERICA COMMANDS THE LARGEST SHARE OF GLYCOMICS MARKET 134
FIGURE 93 ROW: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 135
FIGURE 94 ROW: GLYCOMICS MARKET, BY PRODUCT (2014 VS. 2019) 138
FIGURE 95 MIDDLE EAST AND AFRICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 139
FIGURE 96 PACIFIC AND OCEANIA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 140
FIGURE 97 SOUTH AMERICA: GLYCOMICS MARKET SIZE, BY PRODUCT, 2014 VS. 2019 ($MILLION) 141
FIGURE 98 NEW PRODUCT LAUNCHES IS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS 142
FIGURE 99 GLOBAL GLYCOMICS ENZYMES, KITS AND REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 143
FIGURE 100 GLOBAL GLYCOMICS INSTRUMENTS MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2014 144
FIGURE 101 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES IS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE GLYCOMICS MARKET 146
FIGURE 102 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 152
FIGURE 103 COMPANY SNAPSHOT 153
FIGURE 104 SWOT ANALYSIS 157
FIGURE 105 SWOT ANALYSIS 160
FIGURE 106 COMPANY SNAPSHOT 161
FIGURE 107 SWOT ANALYSIS 165
FIGURE 108 COMPANY SNAPSHOT 166
FIGURE 109 SWOT ANALYSIS 168
FIGURE 110 COMPANY SNAPSHOT 169
FIGURE 111 SWOT ANALYSIS 171
FIGURE 112 COMPANY SNAPSHOT 172
FIGURE 113 SWOT ANALYSIS 175
FIGURE 114 COMPANY SNAPSHOT 176
FIGURE 115 COMPANY SNAPSHOT 180
FIGURE 116 COMPANY SNAPSHOT 186

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...

Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

Genome Editing/Genome Engineering Market by Technology, Applications, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing ...

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

Biochip Market Analysis by Type, Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use, and Segment Forecasts to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.